A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

cited authors

  • Gilbert, Mark R; Dignam, James J; Armstrong, Terri S; Wefel, Jeffrey S; Blumenthal, Deborah T; Vogelbaum, Michael A; Colman, Howard; Chakravarti, Arnab; Pugh, Stephanie; Won, Minhee; Jeraj, Robert; Brown, Paul D; Jaeckle, Kurt A; Schiff, David; Stieber, Volker W; Brachman, David G; Werner-Wasik, Maria; Tremont-Lukats, Ivo W; Sulman, Erik P; Aldape, Kenneth D; Curran, Walter J; Mehta, Minesh P

keywords

  • ADJUVANT TEMOZOLOMIDE
  • CLINICAL-TRIALS
  • COMBINATION
  • GLIOMA
  • General & Internal Medicine
  • Life Sciences & Biomedicine
  • MULTIFORME
  • Medicine, General & Internal
  • PHASE-III
  • RADIATION-THERAPY
  • RECURRENT GLIOBLASTOMA
  • RESPONSE CRITERIA
  • Science & Technology
  • VALIDATION

WoS ID

  • 000331531900005

Digital Object Identifier (DOI)

start page

  • 699

end page

  • 708

volume

  • 370

issue

  • 8